Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rikke Borg

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Diabetes Care|June 10, 2008
Translating the A1C assay into estimated average glucose valuesDavid M Nathan, Judith Kuenen, Rikke Borg, et al.
BMC Primary Care|June 21, 2023
Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and deathRikke Borg, Margit Kriegbaum, Mia Klinten Grand, et al.
Ugeskrift for Laeger|November 17, 2009
[Glycated haemoglobin may in future be reported as estimated mean blood glucose concentration--secondary publication]Rikke Borg, Jørn Nerup, David M Nathan, et al.
Kidney Medicine|June 1, 2026
Impact of Increased SGLT2 Inhibitor Uptake in CKD Management in Denmark: Modeling National Patient Benefits and Cost SavingsRenée Hangaard Olesen, Nicholas Carlson, Jens Søndergaard, et al.
BMJ Open|September 21, 2024
Cohort profile: the PRIMETIME 1 (PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy) cohort - a longitudinal Danish nationwide study of individuals with diabetes and a performed kidney biopsyKarina Haar Jensen, Vanja Kosjerina, Ditte Hansen, et al.
Diabetes Care|June 25, 2011
Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?Judith C Kuenen, Rikke Borg, Dirk J Kuik, et al.
Clinical Kidney Journal|December 4, 2023
Design and methodology of the PRIMETIME 1 cohort study: PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathyKarina Haar Jensen, Frederik Persson, Ditte Hansen, et al.
Cardiovascular Diabetology|December 20, 2025
Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOWPeter Rossing, Morten Lindhardt, Christian Klyver Tikkanen, et al.
Diabetes|April 29, 2010
Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) studyRikke Borg, Judith C Kuenen, Bendix Carstensen, et al.
Infectious Diseases (London, England)|December 10, 2020
Early improvements in pulmonary function after severe COVID-19 requiring mechanical ventilationBarbara Bonnesen, Louise Lindhardt Toennesen, Kirsten Braendholt Rasmussen, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Diabetes Care|June 10, 2008
Translating the A1C assay into estimated average glucose valuesDavid M Nathan, Judith Kuenen, Rikke Borg, et al.
BMC Primary Care|June 21, 2023
Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and deathRikke Borg, Margit Kriegbaum, Mia Klinten Grand, et al.
Ugeskrift for Laeger|November 17, 2009
[Glycated haemoglobin may in future be reported as estimated mean blood glucose concentration--secondary publication]Rikke Borg, Jørn Nerup, David M Nathan, et al.
Kidney Medicine|June 1, 2026
Impact of Increased SGLT2 Inhibitor Uptake in CKD Management in Denmark: Modeling National Patient Benefits and Cost SavingsRenée Hangaard Olesen, Nicholas Carlson, Jens Søndergaard, et al.
BMJ Open|September 21, 2024
Cohort profile: the PRIMETIME 1 (PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathy) cohort - a longitudinal Danish nationwide study of individuals with diabetes and a performed kidney biopsyKarina Haar Jensen, Vanja Kosjerina, Ditte Hansen, et al.
Diabetes Care|June 25, 2011
Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?Judith C Kuenen, Rikke Borg, Dirk J Kuik, et al.
Clinical Kidney Journal|December 4, 2023
Design and methodology of the PRIMETIME 1 cohort study: PRecIsion MEdicine based on kidney TIssue Molecular interrogation in diabetic nEphropathyKarina Haar Jensen, Frederik Persson, Ditte Hansen, et al.
Cardiovascular Diabetology|December 20, 2025
Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOWPeter Rossing, Morten Lindhardt, Christian Klyver Tikkanen, et al.
Diabetes|April 29, 2010
Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) studyRikke Borg, Judith C Kuenen, Bendix Carstensen, et al.
Infectious Diseases (London, England)|December 10, 2020
Early improvements in pulmonary function after severe COVID-19 requiring mechanical ventilationBarbara Bonnesen, Louise Lindhardt Toennesen, Kirsten Braendholt Rasmussen, et al.
Pageof 4